For details about Sopheon's directors and executive management, click here.
Sopheon (LSE:SPE) is an international provider of software and services for product life cycle management. Our Accolade® solution supports strategic roadmapping, idea development, product portfolio management and the creation, commercialization and replacement of products. It enables users to achieve sustainable market differentiation by synchronizing product ideation, planning and innovation process execution. Sopheon has operating bases in the United States, the United Kingdom and the Netherlands, with distribution, implementation and support channels worldwide.
To view the company's latest annual report, interim report, Memorandum & Articles of Association and most recent admission document, click here.
For all announcements made by the company in the previous 12 months and Sopheon’s financial releases from the past year, click here.
To view details regarding the company's registered office, nominated adviser, principal bankers, solicitors, auditors, and other key advisers, click here.
Financial information is published on the company’s website in accordance with legislation in the United Kingdom governing the preparation and dissemination of financial information, which may vary from legislation in other jurisdictions. The maintenance and integrity of the group's website is the responsibility of the directors. The directors' responsibility also extends to the ongoing integrity of the financial information contained therein.
Sopheon has one class of shares, ordinary 5p shares, and 146 million shares in issue. So far, as the company is aware, 11.24% of its securities are not in public hands as defined by the AIM rules. The company is not aware of any restrictions on the transfer of its securities.
Shareholders with a significant notified interest in Sopheon shares are:
B.K. Mence (Director) - 9.9%
Norman Nominees Limited - 8.1%
London Stock Exchange: SPE
Euronext Exchange: SOPH
London Stock Exchange and Euronext: Ordinary Shares
The above information is provided in accordance with AIM Rule 26 and was last updated on December 31, 2011.
In recent years, many companies have become aware that their shareholders have received unsolicited phone calls or correspondence concerning investment matters. These are typically from overseas based “brokers” who target UK shareholders, offering to sell them what often turn out to be worthless or high-risk shares in US or UK investments. These operations are commonly known as “boiler rooms.” These “brokers” can be very persistent and extremely persuasive, and a 2006 survey by the Financial Services Authority (FSA) has reported that the average amount lost by investors is around £20,000.
It is not just the novice investor that has been duped in this way; many of the victims had been successfully investing for several years. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports. If you receive any unsolicited investment advice:
- Make sure you get the correct name of the person and organization.
- Check that they are properly authorized by the FSA before getting involved by visiting www.fsa.gov.uk/register/ and contacting the firm using the details on the register.
- Report the matter to the FSA either by calling 0845 606 1234 or visiting www.moneymadeclear.fsa.gov.uk.
- If the calls persist, hang up.
If you deal with an unauthorized firm, even if you are a UK resident, you will not be eligible to receive payment under the Financial Services Compensation Scheme. The FSA can be contacted by completing an online form at www.fsa.gov.uk/pages/doing/regulated/law/alerts/overseas.shtml.
Details of any share dealing facilities that the company endorses will be included in company mailings.
More detailed information on this or similar activity can be found on the CFEB website www.fsa.gov.uk/Pages/Doing/Regulated/Law/Alerts/form.shtml.